全文获取类型
收费全文 | 2068篇 |
免费 | 195篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 113篇 |
妇产科学 | 52篇 |
基础医学 | 386篇 |
口腔科学 | 21篇 |
临床医学 | 211篇 |
内科学 | 414篇 |
皮肤病学 | 42篇 |
神经病学 | 338篇 |
特种医学 | 74篇 |
外科学 | 196篇 |
综合类 | 27篇 |
一般理论 | 2篇 |
预防医学 | 92篇 |
眼科学 | 20篇 |
药学 | 138篇 |
中国医学 | 1篇 |
肿瘤学 | 116篇 |
出版年
2021年 | 27篇 |
2020年 | 14篇 |
2019年 | 23篇 |
2018年 | 33篇 |
2017年 | 18篇 |
2016年 | 40篇 |
2015年 | 38篇 |
2014年 | 49篇 |
2013年 | 47篇 |
2012年 | 91篇 |
2011年 | 101篇 |
2010年 | 42篇 |
2009年 | 40篇 |
2008年 | 89篇 |
2007年 | 103篇 |
2006年 | 100篇 |
2005年 | 92篇 |
2004年 | 92篇 |
2003年 | 113篇 |
2002年 | 90篇 |
2001年 | 83篇 |
2000年 | 75篇 |
1999年 | 72篇 |
1998年 | 29篇 |
1997年 | 19篇 |
1996年 | 27篇 |
1995年 | 16篇 |
1994年 | 13篇 |
1993年 | 14篇 |
1992年 | 38篇 |
1991年 | 42篇 |
1990年 | 27篇 |
1989年 | 39篇 |
1988年 | 35篇 |
1987年 | 30篇 |
1986年 | 41篇 |
1985年 | 33篇 |
1984年 | 27篇 |
1983年 | 19篇 |
1982年 | 19篇 |
1978年 | 14篇 |
1977年 | 17篇 |
1974年 | 18篇 |
1973年 | 13篇 |
1972年 | 15篇 |
1971年 | 15篇 |
1968年 | 15篇 |
1967年 | 12篇 |
1933年 | 12篇 |
1922年 | 19篇 |
排序方式: 共有2263条查询结果,搜索用时 156 毫秒
1.
Aaron H. Burstein Pharm.D. William G. Reiss Pharm.D. Eric Kantor B.A. Gail D. Anderson Ph.D. 《Pharmacotherapy》1998,18(6):1271-1276
Study Objective . To characterize cytochrome P450 (CYP) 3A4 activity in premenopausal and postmenopausal women by evaluating the urinary 6-β-hydroxycortisokcortisol ratio. Design . Prospective study. Subjects . Thirteen premenopausal and 13 postmenopausal women who were healthy and not receiving drugs known to affect CYP3A4 activity. Interventions . Beginning on day 2 of menses, premenopausal women collected first morning urine samples every other day for a complete menstrual cycle. Postmenopausal women collected first morning urine every other day for 28 days. Measurements and Main Results . Mean weekly 6-β-hydroxycortisol:cortisol ratios did not differ during the phase (week) of the menstrual cycle. Daily ratios did not differ in postmenopausal women. No difference between premenopausal and postmenopausal women was found on comparing overall median ratios. Conclusion . Cytochrome P450 3A4 activity as measured by 6-β-hydroxy cortisol:cortisol ratio did not differ by week of menstrual cycle, suggesting no menstrual cycle-related changes. Menopause does not appear to be associated with differences in CYP3A4 activity, compared with premenopause. 相似文献
2.
3.
4.
G E Hogarty C M Anderson D J Reiss S J Kornblith D P Greenwald C D Javna M J Madonia 《Archives of general psychiatry》1986,43(7):633-642
Relapse rates averaging 41% in the first year after discharge among schizophrenic patients receiving maintenance neuroleptic treatment led to the development of two disorder-relevant treatments: a patient-centered behavioral treatment and a psychoeducational family treatment. Following hospital admission, 103 patients residing in high expressed emotion (EE) households who met Research Diagnostic Criteria for schizophrenia or schizoaffective disorder were randomly assigned to a two-year aftercare study of family treatment and medication, social skills training and medication, their combination, or a drug-treated condition. First-year relapse rates among those exposed to treatment demonstrate a main effect for family treatment (19%), a main effect for social skills training (20%), and an additive effect for the combined conditions (0%) relative to controls (41%). Effects are explained, in part, by the absence of relapse in any household that changed from high to low EE. Only the combination of treatment sustains a remission in households that remain high in EE. Continuing study, however, suggests a delay of relapse rather than prevention. 相似文献
5.
N1303K is one of the most frequent non-delta F508 mutations causing cystic fibrosis in Central Europe. Since no restriction site is altered by this mutation and no other frequent mutations are known so far in exon 21, the detection requires a separate and laborious test. A mismatched primer was used to create an artificial Hin dIII site in amplified wildtype DNA, which is destroyed by the mutation. This allows for rapid and convenient detection by restriction enzyme digestion. 相似文献
6.
7.
8.
S Lu D D Parekh O Kuznetsova S A Green C A Tozzi T F Reiss 《The European respiratory journal》2006,28(4):772-780
Cholinergic antagonists have been used since the early 1900s as bronchodilators for chronic obstructive pulmonary disease (COPD). The present study investigated whether an oral muscarinic M3-selective anticholinergic agent (OrM3) would provide an improved therapeutic advantage compared with an inhaled anticholinergic agent in patients with COPD. A 6-week, multicentre, randomised, placebo- and active-controlled, parallel-group study was performed at 56 sites in the USA. In total, 412 male and female patients (aged 35-86 yrs) with a clinical history consistent with COPD were randomised to receive OrM3 0.5, 2, 3 or 4 mg orally once daily, ipratropium bromide 36 mug by inhalation four times daily or placebo. OrM3 demonstrated a significant dose-related improvement in serial forced expiratory volume in one second and a trend for dose-related improvement in patient-reported symptoms compared with placebo. However, at a dose that provided efficacy less than that of ipratropium, the incidence of dose-related, mechanism-based side-effects for OrM3 exceeded those observed for ipratropium. In patients with chronic obstructive pulmonary disease, the oral M3-selective agent did not offer a therapeutic advantage over inhaled ipratropium. These results do not support the hypothesis that high selectivity for muscarinic M3 receptors over airway neuronal M2 receptors will represent a more effective therapy than current inhaled anticholinergics in obstructive airway disease. 相似文献
9.
10.
Allan L. Reiss Lisa Freund Leslie Plotnick Thomas Baumgardner Kathleen Green Amanda C. Sozer Mark Reader Corinne Boehm Martha B. Denckla 《Annals of neurology》1993,34(1):95-107
Monosomy for the X chromosome is the most frequent cause of Turner's syndrome, a common clinical syndrome associated with particular physical and neurobehavioral features. The results from comprehensive assessment of prepubertal monozygotic female twins discordant for X monosomy are presented. Zygosity was established with DNA Fingerprinting and no evidence of chromosomal mosaicism was seen in either child. Physical features in the affected twin were relatively mild with respect to the full spectrum of physical malformations and disabilities associated with Turner's syndrome. The neurobehavioral phenotypes of the twins were compared. Although both sisters scored in the superior range of intelligence, the affected twin's Performance IQ was 18 points less than her sister, whereas Verbal IQ showed only a 3-point difference between the sisters. Other relative differences were noted within the executive, visuospatial, and visuomotor domains of function. Behavioral evaluation indicated greater problems with attention, hyperactivity, and anxiety in the affected twin. Quantitative analysis of brain anatomy revealed evidence of both general and regional effects of X monosomy on neurodevelopment. Cerebrospinal fluid volume was increased by 25% in the affected twin compared with her sister with a corresponding decrease in gray matter volume. The right frontal, right parietal–occipital, and left parietal-perisylvian regions showed the greatest discrepancy between the sisters with respect to increased cerebrospinal fluid and decreased gray matter volumes in the twin with X monosomy. Differences in the posterior fossa were also noted with a 50% relative increase in the volumes of the fourth ventricle and cisterna magna and a 10 to 15% relative reduction in size of the cerebellar vermis, pons, and medulla in the affected twin. The association between the neurobehavioral and neuroanatomical findings in the affected twin is discussed. The unique nature of the naturally occurring genetic phenomenon seen in this twin pair provides an opportunity to more fully elucidate the neurobehavioral phenotype associated with X monosomy and Turner's syndrome. 相似文献